COVID Drug Recall; Update on Nurse Struck by Lightning; Surrogates’ Pregnancy Risks

Note that some links may require registration or subscription.

Gilead voluntarily recalled one lot of the COVID-19 treatment remdesivir (Veklury) because a customer found a particle of glass in the vial.

Novo Nordisk’s CEO is scheduled to testify on Capitol Hill this morning, likely facing pushback for the high costs of the company’s weight-loss drugs. (NBC News)

Africa has faced a whopping 30,000 suspected cases of mpox this year. (Reuters)

Meanwhile, India reported its first case of the fast-spreading mpox clade 1b. (Reuters)

A nurse struck by lightning last year finally was discharged after more than a year in the hospital. (People)

Prenatal pandemic exposure and maternal SARS-CoV-2 infection were not tied to higher rates of positive autism screens in New York City. (JAMA Network Open)

The first person with eastern equine encephalitis in New York state in a decade died. (New York Times)

Surrogates faced a high risk of pregnancy and postpartum complications. (Annals of Internal Medicine)

Antihypertensive deprescribing was associated with less cognitive decline in nursing home residents, especially those with dementia. (JAMA Internal Medicine)

Most Hispanic adults support abortion access, according to a new poll. (AP)

Maternal influenza infection during pregnancy in Taiwan was tied to increased risk of seizures, but not epilepsy, in offspring. (JAMA Network Open)

Investing $0.24 on digital health interventions per patient each year could save 2 million lives and avert 7 million acute events in the next decade, according to a new WHO report.

Particle Health, a medical records startup, sued Epic Systems for allegedly violating U.S. antitrust law. (Reuters)

Ashwin Vasan, MD, PhD, New York City’s health commissioner since 2022, is stepping down in January. (ABC7)

Lots of people want to quit smoking, and some critics think that drugmakers and the FDA could do more. (STAT)

The American College of Physicians determined that performance measures for pain were lacking. (Annals of Internal Medicine)

Amid growing concerns over microplastics, California accused ExxonMobil of misleading the public about the effectiveness of plastic recycling. (Washington Post)

Please enable JavaScript to view the comments powered by Disqus.